Skip to content
Screener

Monte Rosa Therapeutics, Inc. GLUE Balance Sheet Statement

Q3 '26Q2 '26Q1 '26Q4 '25Q3 '25
$45.18M-78.3%$90.1M+29.8%$159.86M+104%$129.88M-42.1%$208.34M+65.9%
$640.07M+59.3%$631.41M+111%$677.55M+104%$393.19M+4.2%$401.82M+60.0%
$28.63M+3.7%$29.93M+3.0%$28.41M-3.2%$25.99M-11.9%$27.6M-12.2%
$697.73M+51.7%$691.16M+92.2%$736.43M+87.3%$448.66M+2.3%$459.84M+45.9%
$3.35M-76.9%$7.15M+28.1%$7.9M+21.7%$3.55M-79.4%$14.51M+265%
$102.26M-8.6%$105.62M+1,211%$103.64M+515%$111.33M+589%$111.89M+346%
$62.05M+1.0%$59.66M+42.5%$71.04M+20.0%$64.21M-59.1%$61.44M+47.6%
$201.52M-5.8%$203.88M+123%$214.51M+81.7%$215.6M-0.1%$214M+95.2%
$9K+50.0%$9K+50.0%$8K+33.3%$7K+16.7%$6K0.0%
-$562.05M-30.4%-$565.11M-39.9%-$521.72M-33.2%-$477.21M-8.8%-$431.08M+4.6%
$496.21M+102%$487.28M+81.8%$521.92M+89.7%$233.06M+4.5%$245.84M+19.7%
$697.73M+51.7%$691.16M+92.2%$736.43M+87.3%$448.66M+2.3%$459.84M+45.9%

FAQ

What are Monte Rosa Therapeutics, Inc.'s total assets?
Monte Rosa Therapeutics, Inc. (GLUE) holds $697.7M in total assets, up 51.7% year over year.
How much debt does Monte Rosa Therapeutics, Inc. have?
Monte Rosa Therapeutics, Inc. carries $36.3M in total debt against $496.2M of shareholders' equity, a debt-to-equity ratio of 0.07.
How much cash does Monte Rosa Therapeutics, Inc. have?
Monte Rosa Therapeutics, Inc. holds $45.2M in cash and equivalents.
Can Monte Rosa Therapeutics, Inc. cover its short-term obligations?
Its current ratio is 10.32 — current assets exceed current liabilities.
Where does Monte Rosa Therapeutics, Inc.'s balance sheet data come from?
Every line is extracted from Monte Rosa Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.